Your browser doesn't support javascript.
loading
PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes.
Ali, H R; Glont, S-E; Blows, F M; Provenzano, E; Dawson, S-J; Liu, B; Hiller, L; Dunn, J; Poole, C J; Bowden, S; Earl, H M; Pharoah, P D P; Caldas, C.
Afiliação
  • Ali HR; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Pathology, University of Cambridge, Cambridge raza.ali@cruk.cam.ac.uk.
  • Glont SE; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge.
  • Blows FM; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge.
  • Provenzano E; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge.
  • Dawson SJ; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge.
  • Liu B; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge.
  • Hiller L; Warwick Clinical Trials Unit, University of Warwick, Coventry.
  • Dunn J; Warwick Clinical Trials Unit, University of Warwick, Coventry.
  • Poole CJ; Warwick Clinical Trials Unit, University of Warwick, Coventry.
  • Bowden S; Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham.
  • Earl HM; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge.
  • Pharoah PD; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.
  • Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge.
Ann Oncol ; 26(7): 1488-93, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25897014
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Basocelular / Linfócitos do Interstício Tumoral / Antígeno B7-H1 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Basocelular / Linfócitos do Interstício Tumoral / Antígeno B7-H1 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article